John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can ...

Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 ...

Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen on ...

A government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light ...

The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an ...

A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024 ...

The number of prescription drug shortages in the U.S. fell by 23% last year, but a new analysis found other troubling signs ...

GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in ...

Unmet vascular needs can lead to limb loss among unhoused patients. An unusual Massachusetts General Hospital program meets ...

NATIONAL HARBOR, Md. — Hospital finance leaders rolled out the red carpet for the Trump administration’s new health care ...

Dr. Richard Lokudu, the medical director of Mongbwalu General Referral Hospital, has received barely any compensation for his ...

OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect ...